Suppr超能文献

相似文献

3
Potential adverse effects of a low-dose aspirin-diuretic combination on kidney function.
Int J Clin Pharmacol Ther. 2007 Nov;45(11):601-5. doi: 10.5414/cpp45601.
6
Enhanced Renal Clearance in Patients With Hemorrhagic Stroke.
Crit Care Med. 2019 Jun;47(6):800-808. doi: 10.1097/CCM.0000000000003716.

本文引用的文献

2
Empagliflozin in Patients with Chronic Kidney Disease.
N Engl J Med. 2023 Jan 12;388(2):117-127. doi: 10.1056/NEJMoa2204233. Epub 2022 Nov 4.
3
Dapagliflozin in Heart Failure with Mildly Reduced or Preserved Ejection Fraction.
N Engl J Med. 2022 Sep 22;387(12):1089-1098. doi: 10.1056/NEJMoa2206286. Epub 2022 Aug 27.
4
Antiplatelet Therapy in End-stage Renal Disease Patients on Maintenance Dialysis: a State-of-the-art Review.
Cardiovasc Drugs Ther. 2023 Oct;37(5):975-987. doi: 10.1007/s10557-022-07366-4. Epub 2022 Jul 22.
5
Safety and Efficacy of DOACs in Patients with Advanced and End-Stage Renal Disease.
Int J Environ Res Public Health. 2022 Jan 27;19(3):1436. doi: 10.3390/ijerph19031436.
7
Questioning the renoprotective role of L-type calcium channel blockers in chronic kidney disease using physiological modeling.
Am J Physiol Renal Physiol. 2021 Oct 1;321(4):F548-F557. doi: 10.1152/ajprenal.00233.2021. Epub 2021 Sep 6.
8
Empagliflozin in Heart Failure with a Preserved Ejection Fraction.
N Engl J Med. 2021 Oct 14;385(16):1451-1461. doi: 10.1056/NEJMoa2107038. Epub 2021 Aug 27.
9
Sodium Restriction Counseling Reduces Cardiac Events in Patients With Heart Failure.
Circ J. 2021 Aug 25;85(9):1555-1562. doi: 10.1253/circj.CJ-20-1215. Epub 2021 Jun 22.
10
Cardiovascular Disease in Chronic Kidney Disease: Pathophysiological Insights and Therapeutic Options.
Circulation. 2021 Mar 16;143(11):1157-1172. doi: 10.1161/CIRCULATIONAHA.120.050686. Epub 2021 Mar 15.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验